Back to Search Start Over

Synergism of amlodipine and telmisartan or candesartan on blood pressure reduction by using SynergyFinder 3.0 and probability sum test in vivo.

Authors :
Xia, Tian
Xu, Lu‐Lu
Guo, Peng‐Yue
Shi, Wan‐Ting
Cheng, Yan‐Qiong
Liu, Ai‐Jun
Source :
Pharmacology Research & Perspectives; Apr2023, Vol. 11 Issue 2, p1-12, 12p
Publication Year :
2023

Abstract

This study was designed to evaluate the synergism of two couples of antihypertensive drugs (amlodipine + telmisartan and amlodipine + candesartan) on blood pressure reduction in vivo by both SynergyFinder 3.0 and probability sum test. Spontaneously hypertensive rats were treated with intragastric administration of amlodipine (0.5, 1, 2, and 4 mg/kg), telmisartan (4, 8, and 16 mg/kg), candesartan (1, 2, and 4 mg/kg), nine combinations for amlodipine and telmisartan, and nine combinations for amlodipine and candesartan. The control rats were treated by 0.5% carboxymethylcellulose sodium. Blood pressure was recorded continuously up to 6 h after administration. Both SynergyFinder 3.0 and the probability sum test were used to evaluate the synergistic action. The synergisms calculated by SynergyFinder 3.0 are consistent with the probability sum test both in two different combinations. There is an obviously synergistic interaction between amlodipine and telmisartan or candesartan. The combinations of amlodipine and telmisartan (2 + 4 and 1 + 4 mg/kg) and amlodipine and candesartan (0.5 + 4 and 2 + 1 mg/kg) might exert an optimum synergism against hypertension. Compared with the probability sum test, SynergyFinder 3.0 is more stable and reliable to analyze the synergism. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
20521707
Volume :
11
Issue :
2
Database :
Complementary Index
Journal :
Pharmacology Research & Perspectives
Publication Type :
Academic Journal
Accession number :
163021203
Full Text :
https://doi.org/10.1002/prp2.1064